Regenxbio (RGNX) Shares Outstanding (2014 - 2026)
Regenxbio (RGNX) posted quarterly Shares Outstanding (Entity) of $50.9 million for Q4 2025, up 2.71% year-over-year from $49.5 million in Q4 2024, and up 0.54% quarter-over-quarter from $50.6 million in Q3 2025.
Regenxbio (RGNX) Shares Outstanding (2014 - 2026) Analysis & Trends
Regenxbio's Shares Outstanding (Entity) history runs 12 years deep, the most recent figure standing at $50.9 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 2.71% year-over-year to $50.9 million; the TTM figure through Dec 2025 stood at $50.9 million (up 2.71% YoY), while the FY2025 annual figure was $50.9 million, up 2.71% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $50.9 million, up from $50.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $50.9 million in Q4 2025, with the low at $42944.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $43.1 million (2021), against an average of $32.9 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) tumbled 99.9% in 2022, then jumped 113191.68% in 2024.
- Regenxbio's Shares Outstanding (Entity) stood at $42.8 million in 2021, then increased by 1.09% to $43.3 million in 2022, then rose by 1.73% to $44.0 million in 2023, then rose by 12.49% to $49.5 million in 2024, then grew by 2.71% to $50.9 million in 2025.
- Business Quant data shows RGNX's Shares Outstanding (Entity) at $50.9 million in Q4 2025, $50.6 million in Q3 2025, and $50.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn | 52.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.82 Mn |
| Dec 31, 2025 | 51.57 Mn |
| Sep 30, 2025 | 51.69 Mn |
| Jun 30, 2025 | 51.48 Mn |
| Mar 31, 2025 | 51.36 Mn |
| Dec 31, 2024 | 49.51 Mn |
| Sep 30, 2024 | 50.80 Mn |
| Jun 30, 2024 | 50.60 Mn |
| Mar 31, 2024 | 45.73 Mn |
| Dec 31, 2023 | 43.73 Mn |
| Sep 30, 2023 | 43,945.00 |
| Jun 30, 2023 | 43,531.00 |
| Mar 31, 2023 | 43,451.00 |
| Dec 31, 2022 | 43.15 Mn |
| Sep 30, 2022 | 43,251.00 |
| Jun 30, 2022 | 43,111.00 |
| Mar 31, 2022 | 42,944.00 |
| Dec 31, 2021 | 42.44 Mn |
| Sep 30, 2021 | 42.63 Mn |
| Jun 30, 2021 | 42.51 Mn |